• Children (Basel) · Jul 2021

    Review

    Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?

    • Bibhuti B Das, William B Moskowitz, Mary B Taylor, and April Palmer.
    • Department of Pediatrics, Children's of Mississippi Heart Center, University of Mississippi Medical Center, Jackson, MS 39216, USA.
    • Children (Basel). 2021 Jul 18; 8 (7).

    AbstractThis is a cross-sectional study of 29 published cases of acute myopericarditis following COVID-19 mRNA vaccination. The most common presentation was chest pain within 1-5 days after the second dose of mRNA COVID-19 vaccination. All patients had an elevated troponin. Cardiac magnetic resonance imaging revealed late gadolinium enhancement consistent with myocarditis in 69% of cases. All patients recovered clinically rapidly within 1-3 weeks. Most patients were treated with non-steroidal anti-inflammatory drugs for symptomatic relief, and 4 received intravenous immune globulin and corticosteroids. We speculate a possible causal relationship between vaccine administration and myocarditis. The data from our analysis confirms that all myocarditis and pericarditis cases are mild and resolve within a few days to few weeks. The bottom line is that the risk of cardiac complications among children and adults due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection far exceeds the minimal and rare risks of vaccination-related transient myocardial or pericardial inflammation.

      Pubmed     Free full text   Copy Citation  

      Add institutional full text...

    Notes

    hide…